SLFN5
Schlafen family member 5
Also known as: MGC19764, SLFN5_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q08AF3
- Gene
- SLFN5
- Ensembl
- ENSG00000166750
- Chromosome
- 17
- Canonical length
- 891 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Vesicles
OverviewNCBI Gene
Predicted to enable ATP binding activity. Predicted to be involved in cell differentiation. Predicted to be located in nucleus. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
891 residues, UniProt reviewed canonical sequence.
>Q08AF3|SLFN5
1 MSLRIDVDTN FPECVVDAGK VTLGTQQRQE MDPRLREKQN EIILRAVCAL LNSGGGIIKA
61 EIENKGYNYE RHGVGLDVPP IFRSHLDKMQ KENHFLIFVK SWNTEAGVPL ATLCSNLYHR
121 ERTSTDVMDS QEALAFLKCR TQTPTNINVS NSLGPQAAQG SVQYEGNINV SAAALFDRKR
181 LQYLEKLNLP ESTHVEFVMF STDVSHCVKD RLPKCVSAFA NTEGGYVFFG VHDETCQVIG
241 CEKEKIDLTS LRASIDGCIK KLPVHHFCTQ RPEIKYVLNF LEVHDKGALR GYVCAIKVEK
301 FCCAVFAKVP SSWQVKDNRV RQLPTREWTA WMMEADPDLS RCPEMVLQLS LSSATPRSKP
361 VCIHKNSECL KEQQKRYFPV FSDRVVYTPE SLYKELFSQH KGLRDLINTE MRPFSQGILI
421 FSQSWAVDLG LQEKQGVICD ALLISQNNTP ILYTIFSKWD AGCKGYSMIV AYSLKQKLVN
481 KGGYTGRLCI TPLVCVLNSD RKAQSVYSSY LQIYPESYNF MTPQHMEALL QSLVIVLLGF
541 KSFLSEELGS EVLNLLTNKQ YELLSKNLRK TRELFVHGLP GSGKTILALR IMEKIRNVFH
601 CEPANILYIC ENQPLKKLVS FSKKNICQPV TRKTFMKNNF EHIQHIIIDD AQNFRTEDGD
661 WYGKAKFITQ TARDGPGVLW IFLDYFQTYH LSCSGLPPPS DQYPREEINR VVRNAGPIAN
721 YLQQVMQEAR QNPPPNLPPG SLVMLYEPKW AQGVPGNLEI IEDLNLEEIL IYVANKCRFL
781 LRNGYSPKDI AVLFTKASEV EKYKDRLLTA MRKRKLSQLH EESDLLLQIG DASDVLTDHI
841 VLDSVCRFSG LERNIVFGIN PGVAPPAGAY NLLLCLASRA KRHLYILKAS VLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SLFN5 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.23
- Highest tissue expression
- 38 nTPM
Expression across tissuesHPA
Tissue
- thymus: 38 nTPM
- lymph node: 30 nTPM
- tonsil: 27 nTPM
- spleen: 24 nTPM
- appendix: 23 nTPM
- lung: 20 nTPM
Single-cell type
- nk-cells: 176 nCPM
- t-cells: 163 nCPM
- fallopian tube ciliated cells: 144 nCPM
- salivary ionocytes: 130 nCPM
- vascular endothelial cells: 124 nCPM
- fallopian secretory cells: 124 nCPM
Immune cell
- T-reg: 69 nTPM
- NK-cell: 42 nTPM
- naive CD4 T-cell: 38 nTPM
- naive CD8 T-cell: 31 nTPM
- memory CD4 T-cell: 31 nTPM
- MAIT T-cell: 31 nTPM
Brain region
- medulla oblongata: 18 nTPM
- white matter: 17 nTPM
- spinal cord: 15 nTPM
- pons: 13 nTPM
- choroid plexus: 13 nTPM
- thalamus: 13 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.36
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.34
- DepMap mean gene effect
- 0
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SLFN5 as an antibody target. Whether an autoantibody or antibody against SLFN5 could matter depends on whether native SLFN5 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SLFN5 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label SLFN5 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...